Clinical Trials Sponsored by Barcelona Institute for Global Health

Total 3044 results

Barcelona Institute for Global Health

Completed

Pregnant Women for Malaria Surveillance (MiPMon)

P. Falciparum
Barcelona Institute for Global Health

Not yet recruiting

L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

Infections | Infectious Disease | Child, Only
Barcelona Institute for Global Health

Completed

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

Growth | Childhood Obesity | Cardiometabolic Risk
Barcelona Institute for Global Health

Completed

Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms

Attention Deficit Hyperactivity Disorder | Child Behavior Problem | Fatty Acid Deficiency
Barcelona Institute for Global Health

Completed

PHENOTYPE. Therapeutic Study in Barcelona

Poor Mental Health | Natural Outdoor Environments
Barcelona Institute for Global Health

Not yet recruiting

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Infectious Disease | Child, Only | Febrile Illness
Barcelona Institute for Global Health
UNITAID

Active, not recruiting

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (BOHEMIA)

Malaria

Mozambique, Kenya
Jhpiego
Barcelona Institute for Global Health

Completed

TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study (TIPTOP-DRS)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Jhpiego
Barcelona Institute for Global Health

Completed

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies (TIPTOP)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Barcelona Institute for Global Health
Carlos III Health Institute

Completed

Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development (WALNUTs)

Neurobehavioral Manifestations | Vitamin/Nutritional Deficiency

Spain
Universidad Peruana Cayetano Heredia
Barcelona Institute for Global Health

Completed

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 (SAINT-PERU)

Coronavirus Infection | Covid19 | SARS-CoV Infection

Peru
Hospital Universitari Vall d'Hebron Research Institute
Barcelona Institute for Global Health

Completed

Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) (CATCOVID-AIR)

Covid19 | Corona Virus Infection | Acute Respiratory Failure

Spain
Vladimíra Dostálová
Barcelona Institute for Global Health

Recruiting

Testing a Nature-based Socila Intevention on Loneliness: the RECETAS-PRG Trial

Loneliness

Czechia
University of Dschang
Barcelona Institute for Global Health; University of Yaounde 1

Recruiting

Plasmodium Vivax Among Duffy Negative Population in Cameroon. (VIBRANT)

Malaria | Malaria, Vivax | Malaria,Falciparum

Cameroon
Centro de Investigação em Saúde de Manhiça
Barcelona Institute for Global Health

Completed

Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique (MDAM)

Malaria
Clinica Universidad de Navarra, Universidad de...
Barcelona Institute for Global Health

Completed

Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial (SAINT)

Coronavirus Infection | Covid-19 | SARS-CoV-2 Infection

Spain
Universidad Mayor de San Simón
Université Catholique de Louvain; Barcelona Institute for Global Health

Not yet recruiting

Clinical Trial to "Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO) (SAINTBO)

Covid19

Bolivia
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
GSK Vaccines Institute For Global Health S.r.l.

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis

France
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
Centro de Investigação em Saúde de Manhiça
University Health Network, Toronto; Barcelona Institute for Global Health

Completed

Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI)

Malaria

Mozambique
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
GSK Vaccines Institute For Global Health S.r.l.

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Shigellosis

United Kingdom
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
The George Institute for Global Health, China

Completed

Activating Media for Salt Reduction

Hypertensive Disease

China
The George Institute for Global Health, China

Completed

Rehabilitation for Disabled Stroke Patients in Rural China (RECOVER)

Stroke

China
The George Institute for Global Health, China

Completed

China Rural Health Initiative Follow up Study (CRHIFU)

Cardiovascular Disease

China
Hospital Clinic of Barcelona
Barcelona Institute for Global Health; University of Barcelona; Universitat Politècnica... and other collaborators

Enrolling by invitation

An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission (TrackU)

Transmission | Sars-CoV-2 Infection | Empowerment

Spain
Medicines Development for Global Health

Completed

A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years

Onchocerciasis

Ghana
Medicines Development for Global Health

Completed

Dose-finding Study of Moxidectin for Treatment of Scabies

Scabies

Australia, Austria, France
Medicines Development for Global Health

Active, not recruiting

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Onchocerciasis

Congo, The Democratic Republic of the
University of Vic - Central University of Catalonia
Barcelona Institute for Global Health; Public Health Agency of Barcelona; Fundacio...

Recruiting

Testing a Nature-based Social Intervention on Loneliness: the RECETAS-BCN Trial (RECETAS-BCN)

Loneliness

Spain
Medicines Development for Global Health

Recruiting

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Scabies

United States, Honduras
Medicines Development for Global Health

Recruiting

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Onchocerciasis

Côte D'Ivoire, Congo, The Democratic Republic of the
Medicines Development for Global Health

Completed

Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers

QT Effects in Healthy Volunteers

United States
Save the Children
Bill and Melinda Gates Foundation; Aga Khan University; Barcelona Institute for...

Completed

Pediatric Pneumonia Lung Ultrasound (PLUS)

Pneumonia | Acute Respiratory Infection

Pakistan, Mozambique
Amsterdam Institute for Global Health and Development
University of Stellenbosch; Makerere University; Foundation for Innovative New... and other collaborators

Active, not recruiting

Predicting the Future: Incipient Tuberculosis (PreFIT)

Tuberculosis

Uganda, South Africa, Mozambique
Barcelona Centre for International Health Research

Completed

New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease (BIOMARCHA)

Chagas Disease

Spain
Barcelona Centre for International Health Research

Completed

Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease (CINEBENZ)

Chagas Disease

Spain
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation (PROMPT-AF)

Persistent Atrial Fibrillation | Catheter Ablation

China
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Hypertension | Atrial Fibrillation

China
The George Institute for Global Health, China
Changhai Hospital

Recruiting

Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial (LATE-MT)

Acute Ischemic Stroke

China
The George Institute for Global Health, China
Changhai Hospital

Terminated

Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2) (ENCHANTED2)

Acute Ischemic Stroke

China
Duke University
The George Institute for Global Health, China

Completed

Weight Loss Among Adults in Beijing, China

Hypertension | Obesity

China
Medicines Development for Global Health
World Health Organization

Completed

Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis

Ghana
Medicines Development for Global Health
World Health Organization

Completed

Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis

Congo, The Democratic Republic of the, Ghana, Liberia
Craig Anderson
Johns Hopkins University; Genentech, Inc.; The George Institute for Global Health...

Recruiting

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Acute Ischemic Stroke Patients Receiving Reperfusion Therapy

Australia, United Kingdom, United States, Chile, China, Malaysia, Mexico
Lihir Medical Centre
University of Washington; World Health Organization; Barcelona Institute for... and other collaborators

Completed

Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea (YESA-13)

Yaws

Papua New Guinea
University of Sydney
The George Institute for Global Health, India

Terminated

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2)

COVID-19 | SARS-CoV2 Infection

India
The George Institute for Global Health, China
National Health and Medical Research Council, Australia; Global Alliance for...

Completed

SMARTHealth Diabetes in China Using Lay Family Health Promoters

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias

China

Clinical Trials Sponsored by Barcelona Institute for Global Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations